FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Mycophenolate mofetil (Sandoz Inc), signaling an updated/expanded use or labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection Prophylaxis
• Kidney Transplant Rejection Prophylaxis
• Liver Transplant Rejection Prophylaxis
• Systemic Lupus Erythematosus

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)